Gc Therapeutics
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
780 Boylston St Apt 18B, Boston, Massach...Website
www.gc-tx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Gc Therapeutics
GC Therapeutics (GCTx) is a biopharmaceutical company created to scale and unlock the next generation of cell therapy-based medicines. GCTx's platform integrates the latest advancements in synthetic biology, gene editing, cell engineering and machine learning to overcome the therapeutic development and scaling complexities.Explore more
Gc Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gc Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Gc Therapeutics
Click to see if Gc Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Gc Therapeutics recently announced quarterly report
Product Launch: Get notified when Gc Therapeutics launches new products
Funding: Get notified immidiatlly once Gc Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Gc Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Gc Therapeutics is spiking on competitors!
Gc Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Reach out to Masked Content who joined Gc Therapeutics as Masked Content
Find 3 more new buyers
Compare Similar Companies to Gc Therapeutics
Compare insights from companies similar to Gc Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gc Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gc Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gc Therapeutics.
Gc Therapeutics financials insights
Gather financial insights about Gc Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series A
$75M
Gc Therapeutics Tech Stack
A closer look at the technologies used by Gc Therapeutics
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Executive Move
Executive Moves, Board of Directors
Person-Based
Person-Based
New Hire
Executive Move
Executive Moves, New Hire
Gc Therapeutics News & Media
GC Therapeutics Expands Leadership Team with Industry Veterans Kai-Hsin Chang and Azadeh Golipour
CAMBRIDGE, Mass.--(BUSINESS WIRE)--GC Therapeutics (GCTx), a pioneering biotechnology company advancing groundbreaking iPSC-based cell therapies, today announced the appointment of two industry leaders to its executive team. Kai-Hsin Chang, Ph.D., is a former drug development leader at Editas, and will serve as Head of Drug Development, SVP and Azadeh Golipour, Ph.D., is a tech ops veteran previously at AVROBIO joining as Head of Technical Operations, SVP. Dr. Chang brings a wealth of expertiseGC Therapeutics Snares $65 Million Series A
CAMBRIDGE, MA, GC Therapeutics, Inc. (GCTx), announced its launch and completion of a $65 million Series A financing led by Cormorant Asset Management.GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy
CAMBRIDGE, Mass.--(BUSINESS WIRE)--GC Therapeutics, Inc. (GCTx), announced its launch today to scale and unlock the next generation of cell therapy. Invented and developed by a world-class team of scientists in the lab of professor George Church, Ph.D., at Harvard Medical School and the Wyss Institute, GCTx’s induced pluripotent stem cell (iPSC) programming platform, TFome™ (Transcription-Factor-ome, pronounced as tee-eff-ome), integrates the latest advancements in synthetic biology, gene editi
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gc Therapeutics
Sign Up For FreeTo access detailed company insights
GC Therapeutics (GCTx) is a biopharmaceutical company created to scale and unlock the next generation of cell therapy-based medicines. GCTx's platform integrates the latest advancements in synthetic biology, gene editing, cell engineering and machine learning to overcome the therapeutic development and scaling complexities.... Read More
